| |
siRNA Id: | aspsirna3070
|
siRNA Name: | mt1-siRNA
|
Gene: | Tumor protein p53 |
Disease: | Cancer |
Wild allele/target (5'->3'): | GCAUGAACCGGAGGCCCAU
|
Mutant allele/target (5'->3'): | GCAUGAACUGGAGGCCCAU
|
Target Mutation: | c.944C>T,p.R249W
|
Wild siRNA (As strand): | CGUACUUGGCCUCCGGGUA
|
ASP-siRNA (As strand): | CGUACUUGACCUCCGGGUA
|
Mismatch position in siRNA: | A11G |
Mutant allele (5'->3'): | GCAUGAACUGGAGGCCCAU
|
ASP-siRNA (As strand): | CGUACUUGACCUCCGGGUA
|
ASP-siRNA efficacy for mutant allele: | 60
|
Wild allele (5'->3'): | GCAUGAACCGGAGGCCCAU
|
ASP-siRNA (As strand): | CGUACUUGACCUCCGGGUA
|
ASP-siRNA efficacy for wild allele: | 20
|
Percentage discrimination for ASP-siRNA: | 40
|
Wild allele (5'->3'): | GCAUGAACCGGAGGCCCAU
|
Wild siRNA (As strand): | CGUACUUGGCCUCCGGGUA
|
Wild sirna efficacy for wild allele: | 70
|
Wild allele (5'->3'): | GCAUGAACCGGAGGCCCAU
|
ASP-siRNA (As strand): | CGUACUUGACCUCCGGGUA
|
Wild sirna efficacy for mutant allele: | 60
|
Percentage discrimination for wild siRNA: | 10
|
Concentration: | 2 microg |
Orientation: | Double strand |
Mismatch in: | siRNA |
UniProt ID: | P04637 |
Target sequence: | GCATGAACCGGAGGCCCATCCTCACCATCATCA |
Genbank Accesion: | NM_000546 |
Cell-line: | U2OS |
Experimental technique used: | Western blot |
Transfection method: | Lipofectamine |
siRNA expression method: | MWG Biotech |
Post-transfection duration: | 24 hours |
OMID ID: | 191170 |
KEGG disease ID: | H00881 |
Reference: | 12403821 |